BetterLife Pharma (BETRF) Assets Average (2011 - 2026)

BetterLife Pharma has reported Assets Average for 16 years, with the latest figure at $167654.1 in Q2 2026.

• On a quarterly basis, Assets Average rose 4.33% year-over-year to $167654.1 in Q2 2026; TTM through Apr 2026 was $167654.1, a 4.33% increase from a year earlier, with the FY2026 full-year figure at $160649.1, down 20.49% from the prior year.
• Assets Average was $167654.1 for Q2 2026 at BetterLife Pharma, up from $162682.9 in the prior quarter.
• The five-year high for Assets Average was $1.7 million in Q1 2022, with the low at $132801.9 in Q1 2023.
• Average Assets Average over 5 years is $362494.2, with a median of $263573.1 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets Average plunged 94.24% in 2022, then surged 131.92% in 2024.
• Over 5 years, Assets Average stood at $202537.8 in 2022, then jumped by 66.67% to $337571.5 in 2023, then decreased by 21.92% to $263573.1 in 2024, then sank by 37.43% to $164922.5 in 2025, then grew by 1.66% to $167654.1 in 2026.
• The last three Assets Average figures came in at $167654.1 (Q2 2026), $162682.9 (Q1 2026), and $164922.5 (Q3 2025), per Business Quant data.